The Division of Head and Neck Oncology at the James Cancer Hospital and Solove Research Institute is at the forefront of national efforts to improve the outcome of patients treated for head and neck malignancies. During the last competitive renewal application process, the National Cancer Institute characterized the Head and Neck Oncology Program as "excellent."
The current Director is James Rocco, MD, PhD who also holds the inaugural Mary E. and John W. Alford Research Chair in Head and Neck Cancer. The program is currently composed of 21 members from 12 departments in seven colleges.
The goal of the Head and Neck Oncology Program is to develop and support research and educational activities to ultimately improve detection, prevention, rehabilitation and quality-of-life issues relating to head and neck cancer, and to further develop translational, interdisciplinary research and educational programs.
The specific objectives of the program are to:
Improve diagnosis and management of head and neck cancers through collaborative basic and clinical research projects.
Train basic and clinical scientists with an orientation toward translational research.
Evaluate specific risk factors which predict the benefits of pre- and post-operative interventions for individual head and neck cancer patients.